The Weight-Loss Tracker Built Around the GLP-1 Week

MeAgain is built around the GLP-1 daily routine, not just around calories. A generic weight loss tracker app might stop at food and the scale. MeAgain keeps the scale, meals, weekly shot, symptoms, water, protein, fiber, and progress photos in one place, which makes the trend line easier to understand. That matters because GLP-1 weight loss is not only about eating less. It is about navigating weekly medication timing, appetite changes, side effects, and the slower stretches where the scale does not move the way you hoped. The app helps by keeping those signals together instead of scattering them across separate tools. It also gives you more ways to stay engaged, with streaks, Journey Cards, and a home screen widget that keeps daily targets visible. MeAgain has 372,000+ users, a 4.8-star App Store rating across over 16,000 ratings, and the app subscription is $10/month.

The scale is only one part of the story. On GLP-1, the most useful things to track besides weight are protein, water, fiber, the weekly shot, dose changes, and side effects. Those are often the signals that explain why the trend line looks the way it does. If water is low, the week may feel harder. If protein drifts down, the scale might move but the week may feel weaker. If symptoms spike after a dose change, that may explain a stall or a rough stretch better than the number on the scale alone. MeAgain keeps those pieces in one place, so the weight chart has context. That makes it easier to understand plateaus, easier to stay consistent, and easier to bring a clear record to a doctor or licensed clinician. It is especially useful after a rough week, because you can see whether the issue was timing, food, hydration, symptoms, or a mix of all four.

Yes. MeAgain is not just a weight chart with a food log attached. It also keeps the weekly shot, the dose history, the next-dose countdown, the checklist, and the symptom log inside the same app. That matters because the weight trend is easier to interpret when it sits beside the medication routine instead of away from it. If the weekly shot was late, if the dose changed, or if the week felt rough after a step up, the tracker shows that in the same timeline as the scale and meals. The app subscription is $10/month, and eligible subscribers who want the self-pay route can start semaglutide at $129/month or tirzepatide at $199/month through US-based 503A and 503B pharmacies. If the molecule changes later, your history does not get split. That keeps medication timing, symptom patterns, and weight history connected instead of scattering them across separate apps and notes.

Plateaus feel worse when the app only shows the scale. MeAgain helps by showing the rest of the week too. The trend chart smooths out the daily noise, the food log shows whether meals changed, water and protein stay visible, the symptom log captures how the body felt, and the weekly shot history explains whether the routine shifted. That turns a plateau from a blank wall into something you can inspect. Maybe the weight held steady but protein fell. Maybe symptoms eased even though the number did not move. Maybe the weekly shot changed and the scale simply has not caught up yet. The app does not make every plateau disappear, but it does make the slow weeks easier to interpret and easier to talk through with a doctor or licensed clinician. That kind of context makes it easier to stay calm, keep logging, and notice wins that the scale missed.

Download MeAgain, create an account, and set up your weight, food, and weekly medication information. Once that is in place, you can log weigh-ins, meals, water, protein, symptoms, and the weekly shot inside one timeline instead of building a patchwork across different apps. You can get the basics working in a few minutes, then build the habit by logging one weigh-in and one meal at a time. The app subscription is $10/month, month-to-month. If you already take a GLP-1, the tracker works as soon as your weekly shot is configured. If medication access matters later, eligible subscribers can use the in-app self-pay path for semaglutide at $129/month or tirzepatide at $199/month through US-based 503A and 503B pharmacies. That keeps the tracker, the weekly shot, and the optional medication route in one account. The goal is to make the next few months readable enough that you actually keep going.